Neoadjuvant immunotherapy has become a novel approach in several cancers with unparalleled outcomes. This is also true for melanoma, where about 70-80% of patients benefit from these therapies. For the remaining patients our group is hard working on baseline biomarker identification, understanding mechanisms of resistance and identifying novel treatment combinations. These are tested in preclinical models before going into the patient.

The research technician will work in the basic research field in the group of Prof. Christian Blank in close collaboration with the research group of Prof. Karin de Visser.

We are looking for a motivated candidate, with interest in immunologic aspects of cancer therapies, who can work independently in the lab. You have good communication skills and you are able to cooperate within a multidisciplinary team. You have experience with PCR, FACS and T cell culture. A strict requirement is also that you are licensed and experienced in working with animals.

Fixed-term contract: initially 2 years.

Compensation

The employment will be initially for two years, and can be extended in case of good performance. The gross salary, on basis of a full-time employment and depending on experience, will range from € 2.832,- to € 3.824,- per month, according to FWG-function group 45. The terms of employment will be in accordance with general employment rules as laid down in the CAO for hospitals.

The Netherlands Cancer Institute, founded in 1913, is among the top 10 comprehensive cancer centers, combining world-class fundamental, translational, and clinical research with dedicated patient care. Our initiatives to promote excellent translational research have been recognized by the European Academy of Cancer Sciences, when they designated us ‘Comprehensive Cancer Center of Excellence in Translational Research’.